Skip to main content
. 2021 Aug 2;13(15):3892. doi: 10.3390/cancers13153892

Figure 1.

Figure 1

Disease-free survival (DFS) after adjuvant therapy in patients with elevated versus normal biomarker levels: CEA (A), CA19-9 (B), IL-6 (C), CRP (D), and YKL-40 (E); adjusted hazard ratios (HR) and 95% confidence intervals (95% CI).